Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 5/20 | 0.43 |
| ▸ | CTSK | P43235 | 5/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9335239 | 0.81 | PPARA (0.44) | PPARAPPARGPPARDMMP13CTSS | |
| SCHEMBL4864593 | 0.81 | PPARA (0.44) | PPARAPPARGPPARDMMP13CTSS | |
| SCHEMBL9785011 | 0.80 | PPARA (0.58) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL3155606 | 0.80 | PPARA (0.58) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL3160213 | 0.79 | PPARA (0.51) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL26454927 | 0.78 | CA1 (0.42) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL32672499 | 0.78 | PPARA (0.56) | PPARAPPARGPPARDMMP13CTSS | |
| SCHEMBL7943806 | 0.78 | CTSS (0.49) | PPARAPPARGPPARDMMP13CTSS | |
| SCHEMBL13342905 | 0.78 | PPARA (0.46) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL5024738 | 0.78 | CTSS (0.49) | PPARAPPARGPPARDCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042715-A1 | FLUORINATION PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2026-02-12 | — | — | US | disclosed |
| EP-4565550-A1 | FLUORINATION PROCESS | Royal College of Surgeons in Ireland (IE) | 2025-06-11 | — | — | EP | disclosed |
| WO-2024028729-A1 | FLUORINATION PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2024-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042715-A1 | FLUORINATION PROCESS | XDH, VGF, GTF2F1 | PPARA 3614/4885PPARG 797/4885PPARD 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.